KIF2 mediates the neuroprotection in cerebral ischemia injury by affecting NF- κB pathway.

In conclusion, we demonstrate that KIF2 could mediate the neuroprotection in cerebral I/R injury by inhibiting activation of NF-κB pathway. This might provide a novel therapeutic target for cerebral I/R injury. PMID: 31514228 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31514228?dopt=Abstract

Source: Clinical and Experimental Pharmacology and Physiology - September 11, 2019 Category: Drugs & Pharmacology Authors: Wang J, Chen J, Chen J, Liu X, Yang H, Liu J, He A, Gao X, Xin Y Tags: Clin Exp Pharmacol Physiol Source Type: research